Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Sun Pharmaceutical Industries Limited ( (IN:SUNPHARMA) ) has provided an update.
Sun Pharmaceutical Industries Limited announced that the U.S. FDA has classified its Halol facility as ‘Official Action Indicated’ (OAI) following an inspection. This classification indicates non-compliance with certain current good manufacturing practices, resulting in an Import Alert that restricts shipments from the facility to the US, except for certain exemptions due to drug shortages. Sun Pharma is committed to resolving these issues and maintaining compliance to continue providing high-quality medicines worldwide.
More about Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited is a major player in the pharmaceutical industry, primarily engaged in manufacturing and distributing high-quality medicines globally. The company focuses on maintaining compliance with regulatory standards to ensure the safety and efficacy of its products.
Average Trading Volume: 91,928
Technical Sentiment Signal: Hold
Current Market Cap: 3826.1B INR
For a thorough assessment of SUNPHARMA stock, go to TipRanks’ Stock Analysis page.